Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

PAN-301-1

Trial Locations (4)

29572

Carolina Urologic Research Center, Myrtle Beach

35209

Urology Centers of Alabama, Homewood

68130

GU Research Network/Urology Cancer Center, Omaha

90211

Dr. James J. Elist, Beverly Hills

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Accelovance

INDUSTRY

lead

Sensei Biotherapeutics, Inc.

INDUSTRY

NCT03120832 - Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients | Biotech Hunter | Biotech Hunter